Multi-omic markers of intraductal papillary mucinous neoplasms progression into pancreatic cancer
Seminars in Cancer Biology · 2025
DOI: 10.1016/j.semcancer.2024.12.005 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Seminars in Cancer Biology, 2025. Verfasst von Chiara Corradi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, University of Pisa, Pisa, Italy. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Pancreatic Neoplasms, Pancreatic Intraductal Neoplasms, Carcinoma, Pancreatic Ductal. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 226 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Pancreatic ductal adenocarcinoma (PDAC) is the most lethal and common form of pancreatic cancer, it has no specific symptoms, and most of the patients are diagnosed when the disease is already at an advanced stage. Chemotherapy typically has only a modest effect, making surgery the most effective treatment option. However, only a small percentage of patients are amenable to surgery. One viable strategy to reduce PDAC death burden associated with the disease is to focus on precursor lesions and identify markers able to predict who will evolve into PDAC. While most PDACs are believed to be preceded by pancreatic intraepithelial neoplasms (PanINs), 5-10 % arise from Intraductal papillary mucinous neoplasms (IPMNs), which are mass-forming cystic lesions that are very common in the general population. IPMNs offer an invaluable model of pancreatic carcinogenesis for researchers to analyse, as well as a target population for PDAC early detection by clinicians. The evolution of IPMN into cancer is a complex and multistep process, therefore the identification of individual markers will not be the solution. In recent years, multiple omics technologies have been instrumental to identify possible biomarkers of IPMN progression and carcinogenesis. The only foreseeable strategy will be to integrate multi-omics data, alongside clinical and morphological features, into a progression score or signature using either standard epidemiologic tools or artificial intelligence. The aim of this manuscript is to review the current knowledge on genetic biomarkers and to briefly mention also additional omics, such as metabolomics, the exposome, the miRNome and epigenomics of IPMNs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology, University of Pisa, Pisa, Italy.
- Department of Pathology, Koç University School of Medicine and Koç University Research Center for Translational Medicine, Istanbul, Turkey.
- Department of Biochemistry and Molecular Biology, University of Granada, Granada, Spain.
- Division of Pancreatic Surgery and Transplantation, Pancreas Translational and Clinical Research Center, IRCCS San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy.
- Department of Digestive Tract Diseases, Medical University of Lodz, Lodz, Poland.
- Division of Gastroenterology and Research Laboratory, Fondazione IRCCS "Casa Sollievo della Sofferenza" Hospital, San Giovanni Rotondo, Italy.
Zitieren
APA
Corradi, C., Gentiluomo, M., Adsay, V., Sainz, J., Camisa, P. R., Wlodarczyk, B., Crippa, S., Tavano, F., Capurso, G., & Campa, D. (2025). Multi-omic markers of intraductal papillary mucinous neoplasms progression into pancreatic cancer. Seminars in Cancer Biology. https://doi.org/10.1016/j.semcancer.2024.12.005
Vancouver
Corradi C, Gentiluomo M, Adsay V, Sainz J, Camisa PR, Wlodarczyk B, et al. Multi-omic markers of intraductal papillary mucinous neoplasms progression into pancreatic cancer. Seminars in Cancer Biology. 2025. doi:10.1016/j.semcancer.2024.12.005
BibTeX
@article{Corradi2025,
author = {Corradi, Chiara and Gentiluomo, Manuel and Adsay, Volkan and Sainz, Juan and Camisa, Paolo Riccardo and Wlodarczyk, Barbara and Crippa, Stefano and Tavano, Francesca and Capurso, Gabriele and Campa, Daniele},
title = {Multi-omic markers of intraductal papillary mucinous neoplasms progression into pancreatic cancer},
journal = {Seminars in Cancer Biology},
year = {2025},
doi = {10.1016/j.semcancer.2024.12.005}
}
EUVIMED